GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $872,000 | +125.9% | 12,797 | +6.0% | 0.00% | +200.0% |
Q2 2022 | $386,000 | -39.1% | 12,069 | -34.1% | 0.00% | 0.0% |
Q1 2022 | $634,000 | -4.2% | 18,324 | -19.0% | 0.00% | 0.0% |
Q4 2021 | $662,000 | +23.7% | 22,609 | +7.6% | 0.00% | -50.0% |
Q3 2021 | $535,000 | -42.8% | 21,006 | -21.4% | 0.00% | -33.3% |
Q2 2021 | $936,000 | +167.4% | 26,714 | +210.6% | 0.00% | +200.0% |
Q1 2021 | $350,000 | -15.3% | 8,600 | -9.8% | 0.00% | -50.0% |
Q4 2020 | $413,000 | -24.2% | 9,537 | -3.6% | 0.00% | -33.3% |
Q3 2020 | $545,000 | -11.4% | 9,889 | +1.6% | 0.00% | 0.0% |
Q2 2020 | $615,000 | +3.0% | 9,736 | -16.7% | 0.00% | -25.0% |
Q1 2020 | $597,000 | -64.0% | 11,682 | -44.0% | 0.00% | -50.0% |
Q4 2019 | $1,660,000 | +49.8% | 20,877 | -8.6% | 0.01% | +33.3% |
Q3 2019 | $1,108,000 | -4.8% | 22,845 | +3.2% | 0.01% | -14.3% |
Q2 2019 | $1,164,000 | -11.9% | 22,134 | -11.3% | 0.01% | -12.5% |
Q1 2019 | $1,321,000 | +40.1% | 24,955 | +8.7% | 0.01% | +14.3% |
Q4 2018 | $943,000 | -9.2% | 22,968 | -16.0% | 0.01% | 0.0% |
Q3 2018 | $1,039,000 | -19.0% | 27,342 | -3.6% | 0.01% | -22.2% |
Q2 2018 | $1,282,000 | -0.8% | 28,360 | +6.1% | 0.01% | +12.5% |
Q1 2018 | $1,292,000 | +13.1% | 26,740 | -7.9% | 0.01% | 0.0% |
Q4 2017 | $1,142,000 | +35.3% | 29,023 | +6.8% | 0.01% | 0.0% |
Q3 2017 | $844,000 | +20.2% | 27,187 | +6.0% | 0.01% | +14.3% |
Q2 2017 | $702,000 | -12.7% | 25,649 | +17.5% | 0.01% | -12.5% |
Q1 2017 | $804,000 | +103.5% | 21,822 | -20.1% | 0.01% | +100.0% |
Q4 2016 | $395,000 | – | 27,312 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |